UHS Q3 Earnings Soar 44% on Strong Revenue Growth

TL;DR

**UHS crushed Q3, but watch that massive jump in short-term debt – could be a future headache.**

AI Summary

Universal Health Services Inc. (UHS) reported robust financial performance for the three and nine months ended September 30, 2025. Net revenues for the three-month period increased by 13.4% to $4.495 billion from $3.963 billion in the prior year, while net income attributable to UHS surged by 44.1% to $372.957 million from $258.714 million. Diluted earnings per share attributable to UHS rose significantly to $5.86 from $3.80. For the nine-month period, net revenues grew by 10.0% to $12.879 billion from $11.714 billion, and net income attributable to UHS increased by 28.8% to $1.043 billion from $809.700 million. Diluted EPS for the nine months reached $16.07, up from $11.88. Operating charges increased across the board, with salaries, wages, and benefits rising to $2.072 billion for the quarter, up from $1.912 billion. The company also saw a substantial increase in current maturities of long-term debt, jumping to $740.186 million as of September 30, 2025, from $40.059 million at December 31, 2024. Cash provided by operating activities decreased to $1.290 billion for the nine months ended September 30, 2025, compared to $1.409 billion in the same period of 2024, primarily due to changes in accounts receivable.

Why It Matters

UHS's strong Q3 performance, with a 44.1% jump in net income, signals robust demand for healthcare services and effective cost management, which is crucial for investors in the competitive healthcare sector. The significant increase in current maturities of long-term debt to $740.186 million from $40.059 million could impact future liquidity and financial flexibility, warranting close attention from bondholders and equity investors. For employees, continued growth could mean job stability and potential expansion, while customers benefit from a financially healthy provider. In the broader market, UHS's results reflect the resilience of the healthcare industry, potentially influencing investor sentiment towards other hospital operators like HCA Healthcare and Tenet Healthcare.

Risk Assessment

Risk Level: medium — The risk level is medium due to the substantial increase in current maturities of long-term debt, which rose from $40.059 million at December 31, 2024, to $740.186 million at September 30, 2025. This significant increase in short-term obligations could strain liquidity if not managed effectively. Additionally, cash provided by operating activities decreased by $118.96 million for the nine months ended September 30, 2025, compared to the prior year, primarily driven by a $294.210 million change in accounts receivable.

Analyst Insight

Investors should scrutinize the company's plans for managing the $740.186 million increase in current maturities of long-term debt. While the strong earnings are positive, understanding the refinancing strategy and its potential impact on interest expense and cash flow is critical before making further investment decisions.

Financial Highlights

revenue

$4.495B

net Income

$372.96M

eps

$5.86

revenue Growth

+13.4%

Revenue Breakdown

Key Numbers

• $4.495B — Net Revenues (Up 13.4% for Q3 2025 vs. Q3 2024)
• $372.96M — Net Income Attributable to UHS (Up 44.1% for Q3 2025 vs. Q3 2024)
• $5.86 — Diluted EPS Attributable to UHS (Up from $3.80 for Q3 2025 vs. Q3 2024)
• $12.879B — Net Revenues (Up 10.0% for nine months ended September 30, 2025 vs. 2024)
• $1.043B — Net Income Attributable to UHS (Up 28.8% for nine months ended September 30, 2025 vs. 2024)
• $16.07 — Diluted EPS Attributable to UHS (Up from $11.88 for nine months ended September 30, 2025 vs. 2024)
• $740.186M — Current Maturities of Long-Term Debt (Increased from $40.059M at Dec 31, 2024 to Sep 30, 2025)
• $1.290B — Net Cash from Operating Activities (Decreased from $1.409B for nine months ended Sep 30, 2025 vs. 2024)
• $294.210M — Change in Accounts Receivable (Negative impact on cash flow from operating activities for nine months ended Sep 30, 2025)

Key Players & Entities

• UNIVERSAL HEALTH SERVICES INC (company) — registrant
• UHS of Delaware, Inc. (company) — management company and wholly-owned subsidiary
• Universal Health Realty Income Trust (company) — related party, 5.7% owned by UHS
• $4.495 billion (dollar_amount) — net revenues for three months ended September 30, 2025
• $3.963 billion (dollar_amount) — net revenues for three months ended September 30, 2024
• $372.957 million (dollar_amount) — net income attributable to UHS for three months ended September 30, 2025
• $258.714 million (dollar_amount) — net income attributable to UHS for three months ended September 30, 2024
• $740.186 million (dollar_amount) — current maturities of long-term debt as of September 30, 2025
• $40.059 million (dollar_amount) — current maturities of long-term debt as of December 31, 2024
• $1.290 billion (dollar_amount) — net cash provided by operating activities for nine months ended September 30, 2025

FAQ

Risk Factors

• Increased Debt Maturities [high — financial]: The company's current maturities of long-term debt significantly increased to $740.186 million as of September 30, 2025, from $40.059 million at December 31, 2024. This requires substantial cash outflow in the near term to service this debt.
• Rising Labor Costs [medium — operational]: Salaries, wages, and benefits increased to $2.072 billion for the quarter ended September 30, 2025, up from $1.912 billion in the prior year. This rise in operating expenses can pressure profit margins if not offset by revenue growth or efficiency gains.
• Decreased Operating Cash Flow [medium — financial]: Net cash provided by operating activities decreased to $1.290 billion for the nine months ended September 30, 2025, compared to $1.409 billion in the same period of 2024. This was primarily due to a negative change in accounts receivable, indicating slower cash collection.

Industry Context

The healthcare services industry, particularly for providers like Universal Health Services Inc., is characterized by increasing demand driven by an aging population and rising chronic disease rates. However, it also faces significant pressures from evolving reimbursement policies, labor shortages, and the need for continuous technological investment. Competition remains intense among hospital systems, specialized treatment centers, and outpatient facilities.

Regulatory Implications

As a healthcare provider, UHS is subject to extensive federal and state regulations, including those related to patient care, billing practices (e.g., Medicare and Medicaid), and data privacy (HIPAA). Changes in healthcare policy, such as reimbursement rate adjustments or new compliance mandates, can materially impact financial performance and operational costs.

What Investors Should Do

1. Monitor debt servicing capacity
2. Analyze operating expense management
3. Assess cash flow generation trends

Key Dates

• 2025-09-30: Quarter and Nine Months Ended — Reporting period for the 10-Q, showing significant revenue and net income growth but also increased debt maturities and a decrease in operating cash flow.
• 2024-12-31: Previous Year-End Balance Sheet Date — Benchmark for comparison of current assets and liabilities, notably showing a substantial increase in current maturities of long-term debt from this date.

Glossary

Net Revenues

The total revenue generated by the company after deducting returns, allowances, and discounts. (Key indicator of top-line performance and market demand for services.)

Net Income Attributable to UHS

The portion of the company's profit that belongs to the shareholders of Universal Health Services Inc. after all expenses, taxes, and non-controlling interests are accounted for. (Measures the company's profitability for its owners.)

Diluted Earnings Per Share (EPS)

A measure of a company's profit allocated to each outstanding share of common stock, assuming that all convertible securities (like stock options and convertible bonds) were exercised or converted. (Indicates the profitability on a per-share basis, a key metric for investors.)

Current Maturities of Long-Term Debt

The portion of a company's long-term debt that is due to be repaid within the next year. (Highlights short-term liquidity needs and potential refinancing requirements.)

Cash Provided by Operating Activities

The net amount of cash generated from a company's normal business operations over a period. (Indicates the company's ability to generate cash from its core business to fund operations, investments, and debt repayment.)

Year-Over-Year Comparison

Compared to the prior year's reporting period, Universal Health Services Inc. demonstrated strong top-line growth with net revenues up 13.4% for the quarter and 10.0% for the nine months. Net income and EPS also saw substantial increases, reflecting improved profitability. However, a significant concern is the dramatic rise in current maturities of long-term debt, jumping from $40.059 million to $740.186 million, indicating increased near-term financial obligations. Additionally, operating cash flow experienced a decline, primarily due to adverse changes in accounts receivable, suggesting potential headwinds in cash conversion despite revenue growth.

Key Financial Figures

• $0.01 — hich registered Class B Common Stock, $0.01 par value UHS New York Stock Exchan

Filing Documents

• uhs-20250930.htm (10-Q) — 5422KB
• uhs-ex22_1.htm (EX-22.1) — 1051KB
• uhs-ex31_1.htm (EX-31.1) — 11KB
• uhs-ex31_2.htm (EX-31.2) — 10KB
• uhs-ex32_1.htm (EX-32.1) — 7KB
• uhs-ex32_2.htm (EX-32.2) — 7KB
• 0001193125-25-272385.txt ( ) — 16201KB
• uhs-20250930.xsd (EX-101.SCH) — 1536KB
• uhs-20250930_htm.xml (XML) — 2769KB

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Financial Statements (unaudited)

Item 1. Financial Statements (unaudited) Condensed Consolidated Statements of Income – Three and Nine Months Ended September 30, 2025 and 2024 3 Condensed Consolidated Statements of Comprehensive Income – Three and Nine Months Ended September 30, 2025 and 2024 4 Condensed Consolidated Balance Sheets – September 30, 2025 and December 31, 2024 5 Condensed Consolidated Statements of Changes in Equity – Three and Nine Months Ended September 30, 2025 and 2024 6 Condensed Consolidated Statements of Cash Flows - Nine Months Ended September 30, 2025 and 2024 8 Notes to Condensed Consolidated Financial Statements 9

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 28

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk 67

Controls and Procedures

Item 4. Controls and Procedures 67

Other Information

PART II. Other Information

Legal Proceedings

Item 1. Legal Proceedings 68

Risk Factors

Item 1A. Risk Factors 68

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 70

Other Information

Item 5. Other Information 70

Exhibits

Item 6. Exhibits 71

Signatures

Signatures 72 This Quarterly Report on Form 10-Q is for the quarter ended September 30, 2025. This Report modifies and supersedes documents filed prior to this Report. Information that we file with the Securities and Exchange Commission (the "SEC") in the future will automatically update and supersede information contained in this Report. In this Quarterly Report, "we," "us," "our" "UHS" and the "Company" refer to Universal Health Services, Inc. and its subsidiaries. UHS is a registered trademark of UHS of Delaware, Inc., the management company for, and a wholly-owned subsidiary of Universal Health Services, Inc. Universal Health Services, Inc. is a holding company and operates through its subsidiaries including its management company, UHS of Delaware, Inc. All healthcare and management operations are conducted by subsidiaries of Universal Health Services, Inc. To the extent any reference to "UHS" or "UHS facilities" in this report including letters, narratives or other forms contained herein relates to our healthcare or management operations it is referring to Universal Health Services, Inc.'s subsidiaries including UHS of Delaware, Inc. Further, the terms "we," "us," "our" or the "Company" in such context similarly refer to the operations of Universal Health Services Inc.'s subsidiaries including UHS of Delaware, Inc. Any reference to employees or employment contained herein refers to employment with or employees of the subsidiaries of Universal Health Services, Inc. including UHS of Delaware, Inc. 2

FINANCI AL INFORMATION

PART I. FINANCI AL INFORMATION UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF INCOME (amounts in thousands, except per share amounts) (unaudited) Three months ended September 30, Nine months ended September 30, 2025 2024 2025 2024 Net revenues $ 4,495,245 $ 3,963,027 $ 12,878,781 $ 11,714,213 Operating charges: Salaries, wages and benefits 2,071,898 1,912,308 6,037,953 5,611,304 Other operating expenses 1,294,721 1,090,197 3,563,039 3,165,483 Supplies expense 414,583 390,250 1,236,249 1,181,886 Depreciation and amortization 155,060 149,567 455,409 438,050 Lease and rental expense 37,295 36,540 109,348 108,165 3,973,557 3,578,862 11,401,998 10,504,888 Income from operations 521,688 384,165 1,476,783 1,209,325 Interest expense, net 38,431 44,660 113,851 146,385 Other (income) expense, net ( 13,629 ) ( 2,028 ) ( 27,767 ) 3,315 Income before income taxes 496,886 341,533 1,390,699 1,059,625 Provision for income taxes 117,781 75,623 327,354 233,563 Net income 379,105 265,910 1,063,345 826,062 Less: Net income (loss) attributable to noncontrolling interests 6,148 7,196 20,490 16,362 Net income attributable to UHS $ 372,957 $ 258,714 $ 1,042,855 $ 809,700 Basic earnings per share attributable to UHS $ 5.92 $ 3.89 $ 16.27 $ 12.11 Diluted earnings per share attributable to UHS $ 5.86 $ 3.80 $ 16.07 $ 11.88 Weighted average number of common shares - basic 62,974 66,537 64,100 66,873 Add: Other share equivalents 689 1,571 797 1,297 Weighted average number of common shares and equivalents - diluted 63,663 68,108 64,897 68,170 The accompanying notes are an integral part of these condensed consolidated financial statements. 3 UNIVERSAL HEALTH SERVICES, INC. AND SUBSIDIARIES CONDEN

View Full Filing

View this 10-Q filing on SEC EDGAR